E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/16/2013 in the Prospect News PIPE Daily.

Rexahn gives details on $5.3 million registered direct units offering

H.C. Wainwright sells units of one share and a warrant for 0.35 shares

By Devika Patel

Knoxville, Tenn., Oct. 16 - Rexahn Pharmaceuticals, Inc. offered further details about a $5.3 million registered direct offering of units in an 8-K filed Wednesday with the Securities and Exchange Commission. H.C. Wainwright & Co., LLC is the agent for the deal, which priced Oct. 10.

The company will sell 10,192,309 units of one common share and one warrant for 0.35 shares at $0.52 per unit, with each whole warrant exercisable at $0.575 for five years.

The strike price is an 8.49% premium to the Oct. 9 closing share price of $0.53.

Settlement is expected Oct. 16.

Rexahn is a biopharmaceutical company based in Rockville, Md.

Issuer:Rexahn Pharmaceuticals, Inc.
Issue:Units of one common share and one warrant for 0.35 shares
Amount:$5.3 million
Units:10,192,309
Price:$0.52
Warrants:One warrant for 0.35 shares per unit
Warrant expiration:Five years
Warrant strike price:$0.575
Agent:H.C. Wainwright & Co., LLC
Pricing date:Oct. 10
Settlement date:Oct. 16
Stock symbol:NYSE: RNN
Stock price:$0.53 at close Oct. 9
Market capitalization:$66.42 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.